Faircraft develops lab-grown leather derived from animal skin cells using proprietary tissue-engineering and cellular agriculture techniques to replicate the structure and composition of traditional leather. The company operates development and manufacturing laboratories at its Paris headquarters and holds two international patents for its standardized, in‑house production process. Faircraft emphasizes luxury finishing, working with master tanners to adapt the material for premium leather goods. Current manufacturing costs remain higher than traditional leather, but the company says it is on a trajectory toward price parity. The $15.8 million funding will be used to expand the team—notably hiring more engineers and biologists—and to accelerate scaling of operations to meet growing demand.

Total raised

$16M

Funding rounds

1

Latest round

Equity

Latest activity

Nov 2024